Blume Capital Management’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$193K Buy
5,577
+303
+6% +$8.13K 0.03% 122
2026
Q1
$109K Buy
5,274
+2,225
+73% +$52.6K 0.02% 145
2025
Q4
$99K Buy
3,049
+1,025
+51% +$43.9K 0.02% 144
2025
Q3
$115K Buy
2,024
+150
+8% +$7.69K 0.02% 145
2025
Q2
$93.4K Buy
1,874
+492
+36% +$22.2K 0.02% 150
2025
Q1
$40.8K Buy
1,382
+182
+15% +$6.76K 0.01% 193
2024
Q4
$29K Buy
1,200
+600
+100% +$14.9K 0.01% 209
2024
Q3
$11.1K Buy
600
+450
+300% +$8.06K ﹤0.01% 268
2024
Q2
$3.03K Buy
+150
New +$2.5K ﹤0.01% 292

Other funds holding HIMS

Blume Capital Management's HIMS Position: Q2 2026 in Review

Blume Capital Management increased its Hims & Hers Health (HIMS) stake by 5.7% in Q2 2026, buying an estimated $8.13K and bringing the position to 5,577 shares worth $193K. The position accounts for 0.03% of the portfolio, ranked #122.

Blume Capital Management first reported a position in HIMS in Q2 2024 and has held it in 9 quarters since. 189 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Blume Capital Management held 5,577 shares of Hims & Hers Health worth $193K as of Q2 2026.
  • Blume Capital Management bought 303 Hims & Hers Health shares in Q2 2026, an estimated $8.13K.
  • Hims & Hers Health made up 0.03% of Blume Capital Management's portfolio in Q2 2026, its #122 holding.
  • Blume Capital Management first reported a position in Hims & Hers Health in Q2 2024 and has held it in 9 quarters since.
  • 189 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Blume Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.